This week, Dr. Pierre Kory’s powerful Op-Ed for The Brownstone Institute called for advancing global access to medicines with the most effective treatment as the universal goal. These medicines would ideally gain approval by an independent board “free of pharma industry conflicts.” The guiding principles for drug acceptance would be simple: They would be assessed for safety, efficacy, globally availability and affordability.
The Brownstone Institute is a nonprofit 501(c)(3) organization founded May 2021. The impetus for the founding of the Brownstone Institute was the global crisis created by misguided public health policy responses to the COVID-19 pandemic of 2020.
Tennessee’s state legislature passed a law this week that allows ivermectin to be sold or purchased as an over-the-counter medication without a prescription or consultation with a pharmacist or other licensed healthcare professional.
The state’s Board of Pharmacy will be meeting in a couple of weeks to determine how they will carry out the terms of the new law. However, their next scheduled meeting is not until July, so ivermectin may not be available over-the-counter until then—at the earliest. The Board of Pharmacy operates under the auspices of the Tennessee Department of Health.
In addition, the New Hampshire Senate Health and Human Services Committee advanced a bill for OTC ivermectin to the full Senate, where a vote will take place next week.
In his most recent Substack article, Dr. Buzz Hollander of Hawaii says that some people who took Pfizer’s Paxlovid have experienced viral remission with a negative rapid test—only to get sick again and test positive for COVID.
“The FDA was well aware of this rebound in viral loads in a substantial proportion of people treated with Paxlovid, around days 10-14 after starting treatment. For some reason, though, they didn’t think to tell us doctors about it. It’s not in the Fact Sheet for Health Care Providers, and there is only one line even vaguely referencing this possibility in the Fact Sheet for Patients:
Talk to your healthcare provider if you do not feel better or if you feel worse after 5 days.
We absolutely should have been warning patients (and doctors) that rapid improvement, followed by clinical deterioration and, presumably, high risk of contagion, could happen in some 10% of high-risk patients. It’s also quite clear that we need more information about Paxlovid now.”
On his Substack page, Dr. Mobeen Syed discusses studies that look at the impact of spike protein in the blood in some patients who received the mRNA vaccines. “This is a problem that was not supposed to happen,” says Dr. Been. “Spike protein can cross the blood-brain barrier and may also be related to hypercoagulability.”
Topic explored include:
- Vaccine Generated Spike Proteins Circulate in The Blood on Exosomes
- Spike protein gets in the blood of vaccinated individuals.
- Spike Genes Have Patented DNA Sequences. This is Dangerous.
- Spike Protein Goes to Nucleus and Impairs DNA Repair
In this important video, Dr. Been reviews the prevalence of long COVID from data collected in the UK, which he extrapolates for the U.S. Also, Dr. Been reviews a 2020 study demonstrating long COVID in acute COVID patients—while also sharing some compelling new “clues” as to why even some asymptomatic patients can experience long COVID.
On this week’s FLCCC Weekly webinar, we opened up the floor to the audience for a robust Q&A with Dr. Paul Marik and Dr. Pierre Kory. Moderated by host Betsy Ashton, the program featured a mix of brilliant questions posed by our viewers. This is certainly a must-watch for information on shingles post-COVID, Pfizer’s anti-viral drug Paxlovid, COVID and pregnancy, natural immunity, and a lot more.